Horizon Pharma (HZNP) to Acquire Global Interferon Gamma-1b Rights from Boehringer Ingelheim
Tweet Send to a Friend
Horizon Pharma plc (NASDAQ: HZNP) announced that its affiliate has entered into a definitive agreement with Boehringer Ingelheim International GmbH ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE